Ethnopharmacology, Phytochemistry, Pharmacology, Toxicology and Clinical Applications of Radix Astragali

  • Chun-hong Zhang
  • Xiao Yang
  • Jing-ran Wei
  • Na-mu-han Chen
  • Jian-ping Xu
  • Ya-qiong Bi
  • Min Yang
  • Xue Gong
  • Zi-yan Li
  • Kai Ren
  • Qi-heng Han
  • Lei Zhang
  • Xue Li
  • Ming-yue Ji
  • Cong-cong Wang
  • Min-hui LiEmail author


Radix Astragali (RA), a traditional Chinese medicine from the dried root of Astragalus species, is widely distributed throughout the temperate regions of the world. The major bioactive constituents of RA are triterpene glycosides, flflavonoids, saponins, and alkaloids, and these compounds mostly exert pharmacological activities on the cardiovascular, immune, respiratory, and hepatic systems. This review summarizes the recent studies on RA and provides a comprehensive summary regarding the status of resources, ethnopharmacology, phytochemistry, pharmacology, toxicology, clinical application, and patent release of RA. We hope this review can provide a guidance for further development of therapeutic agents from RA.


Radix Astragali ethnopharmacology phytochemistry pharmacology clinical application review 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


Supplementary material

11655_2019_3032_MOESM1_ESM.pdf (388 kb)
Supplementary material, approximately 228 KB.


  1. 1.
    Shao BM, Xu W, Dai H, et al. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun 2004;320:1103–1111.CrossRefPubMedGoogle Scholar
  2. 2.
    Chinese Pharmacopoeia Commission. Chemical Industry Press: Beijing; 2010;283.Google Scholar
  3. 3.
    Fu J, Wang Z, Huang L, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res 2014;28:1275–1283.CrossRefPubMedGoogle Scholar
  4. 4.
    Ma QX, Duan JA, Zhu YD. Chemical comparison of Astragali Radix (Huangqi) from different regions of China. J Nat Med 2000;54:213–218.Google Scholar
  5. 5.
    Zhang LT, Guo BL, Zhu SC, et al. Investigation report on germplasm resources of Astragalus membranaceus. J Chin Med Mater (Chin) 2006;29:771–773.Google Scholar
  6. 6.
    Wang LL, Feng HL, Yang K, et al. Advances in biology and chemical constituents of Astragalus membranaceus. Genomic Appl Biol 2017;36:2581–2585.Google Scholar
  7. 7.
    Chenghao DU, Wan H, Zhang Y, et al. Compatibility rule of ancient and modern application about Astraglus. Chin Arch Tradit Chin Med (Chin) 2016;34:1102–1105.Google Scholar
  8. 8.
    Zhang K, Pugliese M, Pugliese A, et al. Biological active ingredients of traditional Chinese herb Astragalus membranaceus on treatment of diabetes: a systematic review. Mini Rev Med Chem 2015;15:315–329.CrossRefPubMedGoogle Scholar
  9. 9.
    Guo L, Bai SP, Zhao L, et al. Astragalus polysaccharide Injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survival. Med Oncol 2012;29:1656–1662.CrossRefPubMedGoogle Scholar
  10. 10.
    Cui K, Zhang S, Jiang X, et al. Novel synergic antidiabetic effects of Astragalus polysaccharides combined with Crataegus flavonoids via improvement of islet function and liver metabolism. Mol Med Rep 2016;13:4737.CrossRefPubMedGoogle Scholar
  11. 11.
    Zhang BB, Deng MJ, Wang XY, et al. Beauty pharmacology of traditional Chinese medicines for invigorating qi and their application in modern cosmetics. Pharm Clin Mater Med (Chin) 2015;31:235–240.Google Scholar
  12. 12.
    Hong L. Application of Astragalus membranaceus in beauty treatment of traditional Chinese medicine. J New Chin Med (Chin) 2008;40:92.Google Scholar
  13. 13.
    Wang SH. Study on anti-skin photoaging of Astragalus membranaceus [Dissertation]. Shenyang: Liaoning University of Traditional Chinese Medicine, 2004.Google Scholar
  14. 14.
    Huang X, Xu J, Ma W. Application and prospect of traditional Chinese medicine Astragalus on medical cosmetology. Chin Beauty Med (Chin) 2017;26:123–125.Google Scholar
  15. 15.
    Liu SQ, Li BF, Su H, et al. Overview of application of traditional Chinese medicine Astragalus membranaceus in health care products. Heilongjiang Sci Technol Inform (Chin) 2016;31:75–76.Google Scholar
  16. 16.
    Wang XF, Liang Y, Liu DW, et al. Study on genetic diversity of Astragalus membranaceus var. mongholicus populations in Inner Mongolia. Chin J Grassland (Chin) 2018;40:42–48.Google Scholar
  17. 17.
    Liu JQ, Yang JH, Zhu G. Life histories of endangered Astragalus membranaceus population. Pratacultural Sci (Chin) 2011;28:180–184.Google Scholar
  18. 18.
    Qin XM, Li ZY, Sun HF, et al. Status and analysis of Astragali Radix resource in China. Chin J Chin Mater Med (Chin) 2013;38:3234–3238.Google Scholar
  19. 19.
    Zhang HT, Wang J, Cheng ME, et al. Investigation on cultivation and commodity grade in main producing areas of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao. Chin Med Mat (Chin) 2015;38:2487–2492.Google Scholar
  20. 20.
    Yang G, Zeng Y, Guo LP, et al. Research progress on standards of commodity classes of Chinese materia medica and discussion on several key problems. Chin J Chin Mater Med (Chin) 2014;39:1733–1738.Google Scholar
  21. 21.
    Fu P, ed. Hebei flora of China. Beijing: Science Press 1976;1:735–735.Google Scholar
  22. 22.
    Liu J. Investigation on resource distribution and ecological habits of Astragalus Chinensis. Zibo: Chin Med Res Ecol Committee; 2006.Google Scholar
  23. 23.
    Zhao YZ. Study on the origin and distribution of Radix Astragali. Chin Tradit Herbal Drugs (Chin) 2004;35:1189–1190.Google Scholar
  24. 24.
    Flora of China Editorial Committee of Chinese Academy of Sciences, ed. Flora of China. Beijing: Science Press;1993:131.Google Scholar
  25. 25.
    Ma YQ, Zhu ZX, eds. Inner Mongolia flora. Hohhot: Inner Mongolia People’s Publishing House; 1989:309–310.Google Scholar
  26. 26.
    Zhu X. Revision of the Astragalus penduliflorus complex (Leguminosae-Papilionoidae). Nord J Bot 2003;23:283–294.CrossRefGoogle Scholar
  27. 27.
    Zhang M, Kang Y, Zhou L, et al. Phylogenetic origin of phyllolobium with a further implication for diversification of Astragalus in China. Acta Bot Sin 2009;51:889–899.Google Scholar
  28. 28.
    Wan YQ, Li ZY, Qin XM. Verification of specification grading for Astragali Radix goods and consideration about the quality of Astragali Radix. Chin Med U Res Prac (Chin) 2016;30:61–67.Google Scholar
  29. 29.
    Wang P, Ning LH, Li AP, et al. Analysis on export price trend of Astragali Radix. Mod Chin Med 2014;16:577–578.Google Scholar
  30. 30.
    Yu L, Wang ZB, Wang QH, et al. Research progress on pharmacological effects of flavonoids in Astragali Radix. Inf Tradit Chin Med (Chin) 2018;2:104–108.Google Scholar
  31. 31.
    Kitagawa I, Wang H, Saito M, et al. Saponin and sapogenol. XXXV. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (2). Astragalosides I, II and IV, acetylastragaloside I and isoastragalosides I and II. Chem Pharm Bull 1983;31:698–708.CrossRefGoogle Scholar
  32. 32.
    Kitagawa I, Wang H, Yoshikawa M. Saponin and sapogenol. VIII. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (4). Astragalosides VII and VIII. Chem Pharm Bull 1983;31:716–722.CrossRefGoogle Scholar
  33. 33.
    He ZQ, Findlay JA. Constituents of Astragalus membranaceus. J Nat Prod 1991;54:810–815.CrossRefGoogle Scholar
  34. 34.
    Cao ZZ, Yu JH, Gan LX, et al. The structure of astramembrannins. Acta Chimica Sinica 1985;43:581–585.Google Scholar
  35. 35.
    Hirotani M, Zhou Y, Rut H, et al. Cycloartane triterpene glycosides from the hairy root cultures of Astragalus membranaceus. Phytochemistry 1994;37:1403–1407.CrossRefPubMedGoogle Scholar
  36. 36.
    Hirotani M, Zhou Y, Lui H, et al. Astragalosides from hairy root cultures of Astragalus membranaceus. Phytochemistry 1994;36:665–670.CrossRefGoogle Scholar
  37. 37.
    Zhou Y, Hirotani M, Rui H, et al. Two triglycosidic triterpene astragalosides from hairy root cultures of Astragalus membranaceus. Phytochemistry 1995;38:1407–1410.CrossRefGoogle Scholar
  38. 38.
    Kim JS, Yean MH, Lee EJ, et al. Two new cycloartane saponins from the roots of Astragalus membranaceus. Chem Pharm Bull 2008;56:105–108.CrossRefPubMedGoogle Scholar
  39. 39.
    Ma Y, Tian Z, Kuang H, et al. Studies of the constituents of Astragalus membranaceus bunge. III. structure of triterpenoidal glycosides, Huangqiyenins A and B, from the leaves. Chem Pharm Bull 1997;45:359–361.CrossRefGoogle Scholar
  40. 40.
    Kuang H, Zhang N, Tian Z, et al. Studies on the constituents of Astragalus membranaceus II: structure of triterpenoidal glycoside, Huangqiyenin D, from its leaves. Nat Med (Tokyo, Japan) 1997;51:358–360.Google Scholar
  41. 41.
    Ma YL, Tian ZK, Kuang HX, et al. A study on the constituents of stems and leaves of Astragali membranaceus. J Integr Plant Biol 1993;35:480–482.Google Scholar
  42. 42.
    Chu C, Cai HX, Ren MT, et al. Characterization of novel astragaloside malonates from Radix Astragali by HPLC with ESI quadrupole TOF MS. J Sep Sci 2010;33:570–581.CrossRefPubMedGoogle Scholar
  43. 43.
    Yu QT, Li P, Bi ZM, et al. Two new saponins from the aerial part of Astragalus membranaceus var. mongholicus. Chin Chem Lett (Chin) 2007;18:554–556.CrossRefGoogle Scholar
  44. 44.
    Zhu YZ, Lu SH, Okada Y, et al. Two new cycloartanetype glucosides, mongholicoside I and II, from the aerial part of Astragalus mongholicus bunge. Chem Pharm Bull 1992;40:2230–2232.CrossRefGoogle Scholar
  45. 45.
    Wen HY. Research progress in chemical composition of Astragalus. Chin Tradit Pat Med (Chin) 2006;28:879–883.Google Scholar
  46. 46.
    Luo Z, Su MZ, Yan M, et al. Chemical constituents of Astragalus membranaceus var. mongholicus. Chin Tradit Herbal Drugs (Chin) 2012;43:458–462.Google Scholar
  47. 47.
    Wang ZB, Zhu WB, Chen YJ, et al. Flavonoids from the leaves of Astragalus membranaceus. Chin Tradit Pat Med (Chin) 2017;39:1634–1638.Google Scholar
  48. 48.
    Bi ZM, Yu QT, Li P, et al. Flavonoids from the aerial parts of Astragalus mongholicus. Chin J Nat Med (Chin) 2007;5:263–265.CrossRefGoogle Scholar
  49. 49.
    Li YX, Li ZP, Yan SL, et al. Chemical constituents in roots of Astragalus membranaceus. Chin Tradit Herbal Drugs (Chin) 2017;48:2601–2607.Google Scholar
  50. 50.
    Du X, Bai Y, Liang H, et al. Solvent effect in H-1 NMR spectra of 3’-hydroxy-4’-methoxy isoflavonoids from Astragalus membranaceus var. mongholicus. Magn Reson Chem 2006;44:708–712.CrossRefPubMedGoogle Scholar
  51. 51.
    Ye YH. The composition and physiological activity of Astragalus membranaceus. Mod J East Ocean Med 1982;31:46.Google Scholar
  52. 52.
    Wen YH, Cheng L, Zheng D, et al. Chemical constituents of Astragalus membranaceus var. Mongholicus. Pract Pharm Clin Remed (Chin) 2010;13:115–119.Google Scholar
  53. 53.
    Zhang YZ, Xu F, Liang J, et al. Isoflavonoids from roots of Astragalus membranaceus var. mongholicus. Chin J Chin Mater Med (Chin) 2012;37:3243–3248.Google Scholar
  54. 54.
    Horo I, Kocaba F, Alanku-Cali kan O, et al. Secondary metabolites from Astragalus lycius and their cytotoxic activities. Nat Prod Commun (Chin) 2016;11:1847–1850.Google Scholar
  55. 55.
    Song CQ, Zheng ZR, Liu D, et al. Isoflavones from Astragalus membranaceus. J Integr Plant Biol 1997;39:764–768.Google Scholar
  56. 56.
    Choi SI, Heo TR, Min BH, et al. Alleviation of osteoarthritis by calycosin-7-O-β-D-glucopyranoside (CG) isolated from Radix Astragali in rabbit osteoarthritis (OA) model. Osteoarthr Cartilage 2007;15:1086–1092.CrossRefGoogle Scholar
  57. 57.
    Subarnas A, Oshima Y, Hikino H. Isoflavans and a pterocarpan from Astragalus mongholicus. Phytochemistry 1991;30:2777–2780.CrossRefGoogle Scholar
  58. 58.
    Zheng SS, Wang ZT. Chemical constituents from the roots of Astragalus membranace (Fisch.) Bge. Var. mongholicus (Bge.) Hisao. Acta Univ Tradit Med Sin Pharm Shanghai (Chin) 2011;9:89–94.Google Scholar
  59. 59.
    Rui W, Feng YF, Shi ZF, et al. UPLC/Q-TOF-MS study on fingerprint of Astragalus membranaceus obtained from 7 different origin. Chin J Pharm Anal (Chin) 2012;32:602–607.Google Scholar
  60. 60.
    Zhao M, Duan JA, Huang WZ, et al. Isoflavans and Isoflavone from Astragalus hoantchy. J Chin Pharm Univ (Chin) 2002;33:274–276.Google Scholar
  61. 61.
    Bian YY, Guan J, Bi ZM, et al. Studies on chemical constituents of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao. Chin Pharm Aceutical J (Chin) 2006;41:1217–1221.Google Scholar
  62. 62.
    Ma XF. Studies on the chemical constituents of Astragalus membranaceus Bge.var. monhgolieus (Bge.) Hsiao [Dissertation]. Shenyang: Shenyang Pharmaceutical University; 2003.Google Scholar
  63. 63.
    Huang QS, Lv GB, Li YC, et al. Studies on the polysaccharides of “Huang Qi” (Astragalus Mongholicus Bunge.). Acta Pharm Sin 1982;17:200–206.Google Scholar
  64. 64.
    Lu YQ, He XL. The study of chemical composition and pharmacological function on Astragalus L. J Baoding Teach Coll (Chin) 2004;17:40–42.Google Scholar
  65. 65.
    Sun ZH, Shao J, Guo Z. A review on chemical components and pharmacological effects of Huangqi. Clin J Chin Med (Chin) 2015;22–25.Google Scholar
  66. 66.
    Chen GH, Huang WF. Progress in pharmacological effects of compositions of Astragalus membranaceus. Chin J New Drugs (Chin) 2008;17:1482–1485.Google Scholar
  67. 67.
    Xu Y, Bian GW, Wu MY. The effect of Huangqi Injection on immune function in rats with scald. Chin Tradit Patent Med (Chin) 2000;22:494–496.Google Scholar
  68. 68.
    Jin H, Wang JH. Immunomodulatory effects of Astragalus membranaceus and Astragalus polysaccharides from IL-2. Chin J Immunol (Chin) 1989;308–310.Google Scholar
  69. 69.
    Wu XB, Du QY, Liang YL, et al. Effects of Astragalus polysaccharide on immune function of Fei-qi deficiency model mice. China Pharm (Chin) 2012;23:4417–4418.Google Scholar
  70. 70.
    Geng GJ, Jiang J, Du HX, et al. Experimental study on growth inhibition of Astragalus on lung adenocarcinoma cells. Pract Clin J Integr Tradit Chin West Med (Chin) 2011;11:4–5.Google Scholar
  71. 71.
    Song Y, Liu XP, Bai WL, et al. Effect of astragalus on cell proliferation and apoptosis in laryngeal carcinoma cell line. Pract Pharm Clin Remed (Chin) 2013;16:5–7.Google Scholar
  72. 72.
    Zhang Z, Li ZG. Effect of total glucosides of Astragalus on the viability of SCCl5 oral cancer cells and its mechanism. Chin Pract Med (Chin) 2013;8:249–250.Google Scholar
  73. 73.
    Zhou HL, Zhang XL. The protective effect of Astragalus polysaccharides on myocardial ischemia and its mechanisms. Med J West China (Chin) 2012;24:1449–1451.Google Scholar
  74. 74.
    Yu L, Wang ZG, Ma YZ. Myocardial protestive effects of Astragalus pretreatment on ischemic reperfusion injury to rat hearts. Jiujiang Med J (Med) 2002;17:4–6.Google Scholar
  75. 75.
    Mu XF, Guan LH. Effects of Astragaloside extract on cardiomyocyte apoptosis and expression of Bcl-2 in myocardial ischemia reperfusion injury rats. J Shaanxi Univer Chin Med (Chin) 2017;40:103–106.Google Scholar
  76. 76.
    Zhang LL, Liu YQ. Study on the anti-herpes simplex virus activity of a suppository or ointment form of combined with interferon alpha 2b in human diploid cell culture. Chin J Experiment Clin Virol 1998;12:269–271.Google Scholar
  77. 77.
    Wang ZJ, Huang QH. Pharmacodynamic analysis on resisting type II human herpes virus with resveratrol and total Astragalin. J Zhejiang Coll Tradit Chin Med (Chin) 2005;29:80–84.Google Scholar
  78. 78.
    Shi HJ, Zhang ML. An observation of curative effect of Huangqi Injection combined with interleukin-2 in treatment of the patients recurrent herpes simplex keratitis. J Tradit Chin Ophthalmol (Chin) 2000;10:88–90.Google Scholar
  79. 79.
    Zhao ZH. Treatment of herpes simplex keratitis with Polyt: C combined with Astragalus Injection. J Tradit Chin Ophthalmol (Chin) 1993;3:158–159.Google Scholar
  80. 80.
    Mei ZF, Chen JJ, Shi TJ, et al. Inhibitory effect of Astragaloside IV on H1N1 subtype influenza a virus and respiratory synaytial virus. Chin J Animal Infect Dis (Chin) 2017;25:5–10.Google Scholar
  81. 81.
    Wu XM, Yuan WS. In vitro study of the anti-HBV activity of astragalus. Guangdong Med J (Chin) 2008;29:37–38.Google Scholar
  82. 82.
    Yin X, Zhang Y, Wu H, et al. Protective effects of Astragalus saponin I on early stage of diabetic nephropathy in rats. J Pharm Sci 2004;95:256–266.CrossRefGoogle Scholar
  83. 83.
    Yang QX, Xu Q, Huang P, et al. Effect and mechanism of astragaloside IV on Toll-like receptor pathway in fibrotic mice after renal ischemia-reperfusion. Chin J Tradit Chin Med (Chin) 2018;48:1–12.Google Scholar
  84. 84.
    Wang CL, Guo CL, Deng LR, et al. Therapeutic effect of Astragalus membranaceus on nephrotic syndrome in rats. Chin J Integr Tradit West Nephrol (Chin) 2001;12: 4.Google Scholar
  85. 85.
    Wang Y, Liu QG, Wang SS, et al. Progress in treatment of kidney disease with astragalus. J Agricul Sci Yanbian University (Chin) 2016;38:105–108,138.Google Scholar
  86. 86.
    Zhang ZP, Hong JM. Effects of Astragalus polysaccharides on human bone marrow hematopoietic progenitor cells in vitro. Pharmacol Clin Chin Mat Med (Chin) 2000;16:16–17.Google Scholar
  87. 87.
    Zhu SJ, Chen R, Liang JD, et al. Progress in experimental research of Astragalus polysaccharide. J Guiyang Coll Tradit Chin Med (Chin) 2018;40:63–66.CrossRefGoogle Scholar
  88. 88.
    Zhao LF, Zheng YS, Piao HS, et al. Antisenility effects of astragalus polysaccharide and total ginsenoside on senile mice. J Med Sci Yanbian Univer (Chin) 2006;29:249–251.Google Scholar
  89. 89.
    Qu YZ, Zhao Yl, Li M, et al. Protective effect of astragaloside IV on blood-brain barrier and expression of occluding protein after cerebral ischemia and reperfusion. Stroke Nerv Dis 2010;17:92–96.Google Scholar
  90. 90.
    Sang QL. An experimental study on enhancing peripheral nerve regeneration of astragalus polysaccharides in rats [Dissertation]. Changchun: Jilin University, 2008.Google Scholar
  91. 91.
    Zhang YD, Shen J, Song J, et al. Analgesic and sedative effects of Astragalus saponins. J Nanjing Med Coll (Chin) 1984;4:225–227.Google Scholar
  92. 92.
    Huang XP, Wang B, Qiu YY, et al. Effects of astragaloside IV with active components in Panax notoginseng on energy metabolism in brain tissues after cerebral ischemic-reperfusion in mice. Chin Tradit Herb Drug (Chin) 2014;45:220–226.Google Scholar
  93. 93.
    You LZ, Lin YX, Fang ZH, et al. Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects. China J Tradit Chin Med (Chin) 2017;42:4700–4706.Google Scholar
  94. 94.
    Wang N, Zhang D, Mao X, et al. Astragalus polysaccharides decreased the expression of PTP1B through relieving ER stress induced activation of ATF6 in a rat model of type 2 diabetes. Mol Cell Endocrinol 2009;307:89.CrossRefPubMedGoogle Scholar
  95. 95.
    Han D. Study of Astragalosides on antihyperglycemia, regulating plasma lipid and improving antioxidant ability in experimental diabetic rats. J Integr Tradit Chin West Med (Chin) 2016;25:360–364.Google Scholar
  96. 96.
    Li ZY. Effects of aqueous extract of Huangqi on hypertension and myocardial fibrosis induced by hypertension [Dissertation]. Shenyang: Liaoning University Traditional Chinese Medicine; 2016.Google Scholar
  97. 97.
    Wang HQ, Sun MJ, Wu Q, et al. Effects of Astragalus polysaccharides on oxidative stress in umbilical vein endothelial cells after Ischemia-reperfusion injury. J Basic Chin Med (Chin) 2018;24:600–603.Google Scholar
  98. 98.
    Li WP, Ming L, Zhang Y, et al. Experimental study on the anoxic effect of Huang Maoduo sugar. Acta Universitatis Medicinalis Anhui (Chin) 1995;30:184–185.Google Scholar
  99. 99.
    Liang YQ. Antioxidant and anti-inflammation effects of Astragalus polysaccharides on Eahy.926 cell. Southern Med Univ (Chin) 2013.Google Scholar
  100. 100.
    Lin N, Pan JQ, Guan N. Diuretic mechanism of Astragalus in mice and its material basis. Pharm Today 2014;24:481–488.Google Scholar
  101. 101.
    Zhang R, Li K, Li AP, et al. 1H NMR-based metabolomics analysis of the anti-fatigue effects of Astragali Radix based on muscle tissue pubescentis. Acta Pharm Sin 2018;53:782–790.Google Scholar
  102. 102.
    Cheng P, Bai YL, Hu CL, et al. Inhibitory effect of Astragaloside on osteoporosis in ovariectomized rats by regulating Fox O3a/Wnt2/ β-catenin pathway. Chin J Exp Tradit Med Form (Chin) 2018;24:161–166.Google Scholar
  103. 103.
    Xu ZM, Chen JY, Li XF, et al. The role of total flavonoids of Astragalus on human mesenchymal stem cells in protection radiation. Chin Med Pharmacol Clinic (Chin) 2011;27:39–41.Google Scholar
  104. 104.
    Guo Z, Zou J, Zhang X, et al. Anti-inflammatory effect of total flavonoids of Astragalus in vivo. Prog Vet Med 2015;36:64–66.Google Scholar
  105. 105.
    Xiong P, Jiang LZ, Liao XQ. Morphological investigation of the protective effect of astragaloside preconditioning against ischemia-reperfusion lung injury in rats. J South Med Univ() 2010;30:1864–1867.Google Scholar
  106. 106.
    Wu J, Yao XZ. Anti-inflammatory effect of Astragalus polysaccharides and the mechanism inhibiting TRL4/NF-κB pathway in COPD inflammatory response. J Xi’an Jiaotong Univ(Med Sci) 2018;39:760–764.Google Scholar
  107. 107.
    Lu S. Research progress on pharmacological action of Astragalus. J North Pharm (Chin) 2015;12:95.Google Scholar
  108. 108.
    Wang L, Wang DQ, Tian YP, et al. 30-day feeding test of total flavonoids from Astragalus membranaceus. J Toxicol 2004;18:284.Google Scholar
  109. 109.
    Guo XQ. Study on stability and toxicology of Astragalus membranaceus total glycoside oral liquid [Dissertation]. Jiamusi: Jiamusi University, 2005.Google Scholar
  110. 110.
    Rios JL, Waterman PG. A review of the pharmacology and toxicology of Astragalus. Phytother Res 1997;11:411–418.CrossRefGoogle Scholar
  111. 111.
    Yu YS, Ouyang TH, Yang YJ, et al. Subchronic toxicity studies of Radix Astragali extract in rats and dogs. J Ethnopharmacol 2007;110:352–355.CrossRefPubMedGoogle Scholar
  112. 112.
    Cui W, Liu AZ, Xie Q, et al. Effects of Astragalus polysaccharides combined with neoadjuvant chemotherapy TP regimen on myeloid derived suppressor Treg and MDSC cells in cervical cancer patients. South Chin J Defense Med (Chin) 2018;32:238–241.Google Scholar
  113. 113.
    Yang XL. Huangqi polysaccharides Injection combined with radiotherapy for gastric cancer treatment. Chin J Microecol (Chin) 2017;29:66–70.Google Scholar
  114. 114.
    Wang H, Wei PF. Huangqi Jiangtang Pill treating 60 cases of type 2 diabetes. Mod Tradit Chin Med (Chin) 2018;30:24–27.Google Scholar
  115. 115.
    Lu HS, Lou WM. Observation of curative effect of RA Injection on acute exacerbation of chronic pulmonary heart disease. Chin Med Engineer (Chin) 2014;22:39–40.Google Scholar
  116. 116.
    Teng HY. Clinical efficacy of Danshen and AR Injection in the treatment of patients with pregnancy-induced hypertension. Med Equip (Chin) 2018;31:106–107.Google Scholar
  117. 117.
    Liu XY. Analysis of the clinical effect of benazepril hydrochloride Tablets and RA in the treatment of chronic nephritis. World Latest Med Inf Digest (Chin) 2016;16:87–88.Google Scholar
  118. 118.
    An ZP. Clinical observation of RA Jianzhong Decoction combined with omeprazole in treating gastric ulcer. World Latest Med Inf Digest (Chin) 2017;93:168.Google Scholar
  119. 119.
    Chen GZ. Clinical efficacy of ambroxol hydrochloride combined with RA Injection in the treatment of chronic obstructive pulmonary disease. J Clin Med (Chin) 2017;14616.Google Scholar
  120. 120.
    Chen YW, Yang ZP, Fang S. Analysis of China’s technological innovation capability based on the present situation of invention patents. Sci Tech Manage Res 2009;31:104–110.Google Scholar
  121. 121.
    Wang SF, Jin LS, Zheng JS. Development and patent analysis of Rhodiola health food in China. Strait Pharm J 2017;29:43–47.Google Scholar
  122. 122.
    Qin XM, Li AP, Li K, et al. Thinking on development of Shanxi Astragali Radix industry. China J Chin Met Med (Chin) 2016;24:4670–4674.Google Scholar

Copyright information

© The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Chun-hong Zhang
    • 1
  • Xiao Yang
    • 2
  • Jing-ran Wei
    • 2
  • Na-mu-han Chen
    • 1
  • Jian-ping Xu
    • 1
  • Ya-qiong Bi
    • 3
  • Min Yang
    • 1
  • Xue Gong
    • 1
  • Zi-yan Li
    • 1
  • Kai Ren
    • 1
  • Qi-heng Han
    • 1
  • Lei Zhang
    • 2
  • Xue Li
    • 2
  • Ming-yue Ji
    • 1
  • Cong-cong Wang
    • 1
  • Min-hui Li
    • 1
    • 3
    Email author
  1. 1.Department of PharmacyBaotou Medical CollegeBaotou, Inner Mongolia Autonomous RegionChina
  2. 2.Department of PharmacyInner Mongolia Medical UniversityHohhotChina
  3. 3.Pharmaceutical LaboratoryInner Mongolia Institute of Traditional Chinese MedicineHohhotChina

Personalised recommendations